Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Metformin Hydrochloride

Brands: Glumetza · Metformin Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6809
US makers7 labelers
Packages29
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.100$0.200$0.301$0.401Dec 2025Apr 2026Jul 2026
$0.293
Latest avg · Jul 22, 2026
-16%
Since Dec 17, 2025
6
Active US suppliers
54%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.3K2.6K3.9K5.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.9K
Rx · 2026 Q1
335K
Units dispensed
-1%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Micro Labs Limitedunknown8SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown7SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown6SUPPLYING
Santarus, Inc.unknown3SUPPLYING
Oceanside Pharmaceuticalsunknown2SUPPLYING
Westminster Pharmaceuticals, LLCunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown1EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 13, 2025
    RECALLRecall (Class II): Metformin Hydrochloride Extended-Release Tablets 1000mg, 90-count bottle. Manufactured by: Glenmark Pharmaceuticals Lim…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide